Business Context and Reporting Period
Bicycle Therapeutics plc filed a Form 8-K dated April 7, 2021, with the report signed April 9, 2021. The filing concerns a board director’s retirement and does not report quarterly or annual financial results.
Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating or financial metrics.
Material Corporate Change
Kate Bingham notified the board that she will not seek re-election as a Class II director. She will retire from the board at the close of the company’s annual general meeting scheduled for June 28, 2021.
The filing states that Ms. Bingham’s decision was not due to any disagreement with the company concerning its operations, policies, or practices.
Outlook, Risks, and Unusual Items
No changes to management guidance, business outlook, contingencies, or material risks are disclosed. The principal disclosed event is the planned board retirement.
Investor Verification Items
- Verify completion of Kate Bingham’s retirement at the June 28, 2021 annual general meeting.
- Review subsequent filings for the election or appointment of her successor and any resulting board-composition changes.
- Consult the company’s financial filings separately for financial performance, liquidity, cash runway, and operating outlook, which are not included in this Form 8-K.